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In infectious disease immunology, inducible nitric oxide (NO) synthase-derived NO is believed to function
primarily as an antimicrobial and immunoregulatory molecule. In this issue of Immunity, Cole et al. (2012)
show that NO helps the intracellular bacteria Listeria monocytogenes to spread.For patients and medical doctors, Listeria
monocytogenes is a threatening bacte-
rium, which can cause severe septicemia
in the newborn and meningoencephalitis
in immunocompromised or elderly peo-
ple. Considering that the primary port
of entry into the host organism is the
gastrointestinal tract after the con-
sumption of contaminated milk products,
it is clear that this pathogen is capable
to disseminate. For cell biologists,
L. monocytogenes is a highly fascinating
Gram-positive rod because of its paradig-
matic intracellular lifestyle. Extracellular
L. monocytogenes bacteria are rapidly
endocytosed and initially end up in
a phagocytic vacuole (primary infection).
From there the pathogen escapes into
the less hostile cytosol, a process that is
dependent on the secreted pore-forming
listeriolysin O (LLO) and two phospholi-
pases. Within the cytosol the actin-nucle-
ating protein ActA of L. monocytogenes
triggers the polymerization of host cell
actin filaments. This causes the appear-
ance of comet-like tails and the intracel-
lular propulsion of the bacteria with the
formation of Listeria-containing pseu-
dopod projections. The actin coat also
protects the bacteria from rapid autoph-
agy in the cytosol. Cell-to-cell spreading
occurs, when the pseudopods are en-
gulfed by neighboring cells (secondary
infection) (Witte et al., 2012; Figure 1).
For immunologists, L. monocytogenes
has become one of the most-studied
pathogens that, however, still keep
some secrets. Control of Listeria is strictly
dependent on cellular immunity that is
dominated by neutrophils, natural killer
(NK) cells, macrophages, and CD8+ T
lymphocytes. Both interferon (IFN)-g
and tumor necrosis factor (TNF) are
essential for the defense against Listeria.
L. monocytogenes elicits a fulminantinnate inflammatory response, which
involves the myeloid differentiation pri-
mary response gene (MyD88)-dependent
pathway, the interferon-regulatory-factor
3-dependent signaling cascade, and the
inflammasome. Type I interferon triggered
by L. monocytogenes is implicated in
macrophage deactivation and macro-
phage and lymphocyte cell death (Witte
et al., 2012). One of the still unresolved
issues is thequestionof howmacrophages
kill intracellular L. monocytogenes during
primary and secondary infection. In the
past, the analysis of the usual suspects,
i.e., the phagocyte NADPH oxidase
(Phox) and the inducible or type 2 NO syn-
thase (iNOSorNOS2), has yielded conflict-
ing results, not only between cell culture
and mouse studies but also when
comparing in vitro data of different groups
(reviewed in Bogdan, 1997; Edelson and
Unanue, 2002; Shiloh et al., 1999). The
study by Cole et al. (2012) in this issue of
Immunity might help to explain some of
the previous discrepancies, but also points
to new complexities.
Cole et al. (2012) set out to dissect the
process of primary versus secondary
infection of mouse bone marrow-derived
macrophages with L. monocytogenes.
To this end, they developed a flow
cytometry-based assay with differentially
labeled donor and recipient macro-
phages and with green-fluorescent-
protein expressing wild-type or ActA
mutant Listeria. This approach was com-
plemented by a confocal laser scanning
microscopy-based assay and by classical
plaque assays.
During primary infection, the authors
observed that macrophages from wild-
type and Nos2/ mice were equally
potent in killing L. monocytogenes after
pretreatment of the cells with the Toll-
like receptor (TLR)-4 agonist lipopolysac-Immunitycharide (LPS). This result is in line with the
insensitivity of L.monocytogenes to direct
killing by NO and with a series of previous
findings obtained with unstimulated,
IFN-g-, IFN-g plus LPS-, or IFN-g plus
TNF-stimulated macrophages from wild-
type, Nos2/, or NOS2-inhibitor-treated
macrophages, which all failed to find
a correlation between NO production
and listerial killing (Bogdan, 1997; Edel-
son and Unanue, 2002; Shiloh et al.,
1999). It is still possible that NOS2 and/or
Phox oxidize LLO and inhibit the phago-
somal escape during the primary infection
phase in macrophages stimulated with
cytokines plus LPS (Myers et al., 2003);
however, this process is likely to be
antagonized by the g-interferon-inducible
lysosomal thiol reductase (GILT) (Singh
et al., 2008; Figure 1).
In order to analyze the process of
secondary infection and bacterial
spreading, highly infected donor macro-
phages were mixed with a 10-fold excess
of recipient macrophages that had been
pretreated with LPS or other TLR
agonists. TLR activation of the recipient
macrophages led to enhanced bacterial
spreading after 15–18 hr of coincubation,
which directly correlated with the amount
of NO produced. This phenotype required
the expression of ActA by the bacteria
and of NOS2 by the recipient macro-
phages; the enhanced spreading was
not observed if only the donor cells were
NOS2 positive. Unexpectedly, stimulation
of recipient macrophages with IFN-g
alone was insufficient to trigger Listeria
spreading, although the amount of NO
produced was comparable to the
amounts obtained with LPS-stimulated
macrophages. In the absence of any
exogenous TLR- or IFN-g stimulus,
cathepsin D and Phox helped to contain
the bacteria (Figure 1).36, May 25, 2012 ª2012 Elsevier Inc. 697
Figure 1. Infection Phase-Dependent Fate of L. monocytogenes in Macrophages
Primary infection of macrophages with L. monocytogenes. After endocytosis extracellular bacteria end up
in a primary, single membrane vacuole (PV). Listeria escape into the cytosol by the action of pore-forming
listeriolysin O (LLO) and phospholipases A and B (not depicted). NO and superoxide (O2
), generated by
TLR- and/or IFN-g-induced Phox and NOS2, can impair the activity of LLO and phospholipases, which,
however, might be rescued by the IFN-g-inducible thiolreductase (GILT). LLO itself was shown to inhibit
the recruitment of Phox towards the phagosome (Lam et al., 2011). NOS2- and Phox-independent killing
of Listeria can result from phagolysosome (PL) formation or other IFN-g-inducible mechanisms (e.g. acti-
vation of autophagosomes [AP]; recruitment of vesicles carrying guanylate-binding proteins [Gbps] that
support the assembly of Phox). The actin-nucleating protein (ActA) allows a few Listeria to spread.
Secondary infection of macrophages with L. monocytogenes. In the absence of exogenous stimuli
Phox and cathepsin D contribute to the control of Listeria in secondary, double membrane vacuoles
(SV; left). A few bacteria will escape. IFN-g alone triggers NO release, which inhibits the proton-pumping
activity of V-ATPase and the formation of PL (middle). (NB: Whether or not NO inhibits V-ATPase also
under primary infection conditions, has not been addressed). IFN-g prevents bacterial spreading in
a NOS2-independent manner (e.g. via Gbps and activation of AP). Only few bacteria escape. Stimulation
with LPS (±IFN-g) triggers NO release, which inhibits PL formation and V-ATPase activity (right). IFN-g-
inducible mechanisms (e.g. Gbps, AP) are postulated to be blocked by unknown TLR-dependent signals
so that many Listeria will manage to spread.
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PreviewsCole et al. could exclude that NO
promotes the growth of Listeria in the
cytosol, increases the formation or
phagocytosis of pseudopods, or acti-
vates LLO or phospholipases. Instead,
NO appeared to inhibit phagolysosomal
fusion. Phagosome maturation is charac-
terized by the activation of the vacuolar-
type H+-ATPase (V-ATPase) leading
to phagosomal acidification, by the loss
of the early endosomal marker Rab5,
and by acquisition of the lysosomal
membrane protein-1 (LAMP-1). The addi-
tion of two different V-ATPase-inhibitors
(bafilomycin and concanamycin A) did
not affect LPS-enhanced infection of
recipient macrophages. In the presence
of a NOS2 inihibitor, however, both
compounds restored bacterial spreading.698 Immunity 36, May 25, 2012 ª2012 ElseviThese findings are compatible with the
notion that NO at least partially acts via
downregulation of V-ATPase, which is
a well-established inhibitory activity of
NOS2. By using either latex beads or
carboxylated beads, which somewhat
mimic the uptake of free extracellular
bacteria (primary infection) and the
engulfment of pseudopods (secondary
infection), respectively, the authors
observed that NO delayed the loss of
Rab5 and the acquisition of LAMP-1.
The retarded phagolysosomal fusion after
LPS treatment or exposure to a NO donor
was paralleled by an increased number of
Listeria appearing in the cytosol and co-
localizing with actin.
Finally, the group addressed the ques-
tion of whether inhibition of NOS2 mighter Inc.prevent bacterial spreading in vivo.
Indeed, when mice infected with wild-
type L. monocytogenes were treated
with an NOS2 inhibitor, the bacterial load
in the liver was 10-fold lower than in the
control group, whereas no difference
was observed in the spleen.
The work by Cole et al. has several
implications. First, it offers an explanation
for the previous failure to detect an
impact of NOS2 on the overall fate of
L. monocytogenes in macrophages
in vitro. Given that most earlier studies
did not differentiate between primary and
secondary infections, the antibacterial
activities of macrophages during the
primary phaseand theprobacterial effects
of NO during the secondary phase
presumably offset each other. Second,
the observation that IFN-g alone induces
NOproduction by recipientmacrophages,
but at the same time prevents bacterial
spreading, is intriguing. It points to
IFN-g-inducible, but NOS2-independent
effector molecules such as the IFN-g-
inducible GTPases (MacMicking, 2012)
that might counteract the probacterial
effect of NO. Notably, bacterial spreading
was restored when IFN-g was combined
with the nonlisterial TLR signal (LPS).
This could be due to the LPS-mediated
induction of cytokines (e.g., IFN-a/b)
that antagonize the activity of IFN-g
as previously shown by the authors
and others or result from a massively
increased NO release. The finding is
potentially clinically relevant because
severe listeriosis ismostly seen in patients
with underlying other conditions (e.g.,
prematurity, organ transplantation, dia-
betes) that either facilitate the penetration
of bacteria (including LPS-positive,
Gram-negative pathogens) and/or per se
lead to the production of NO. A final issue
raised by the work of Cole et al. relates to
the organ specificity of the observed
effects. Why does a NOS2 inhibitor
partially prevent spreading of Listeria
in the liver, but not in the spleen at
day 2 after infection? There is no straight-
forward answer to this question, particu-
larly because the data of Cole et al.
are in conflict with previous studies, in
which a global NOS inhibitor (NG-mono-
methyl-L-arginine) caused a striking
reduction of the bacterial load in liver and
spleen (day 3 and 7; reviewed in Bogdan,
1997), whereas Nos2/ mice showed
significantly increased numbers of Listeria
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(Shiloh et al., 1999). Upon stimulation
with cytokines (IL-1b, IL-6, TNF, and
IFN-g) or IFN-gplusLPS,bothKupffer cells
and hepatocytes produced high amounts
of NO in vitro, especially when they were
derived from L. monocytogenes-infected
mice, and exhibited strong antilisterial
activity (in a primary infection situation),
which, however, was NOS2 independent
(Bogdan, 1997). After intravenous infection
of mice, L. monocytogenes is initially trap-
ped by Kupffer cells in the liver (primary
infection), but then rapidlyenters intohepa-
tocytes (secondary infection). According to
themodel ofColeet al., the latterprocess is
catalyzed byNO. In the spleen, in contrast,
there is no parenchymal correlate to the
hepatocytes, so that the entire early infec-
tion process will be restricted to resident
macrophages (primary infection situation)
and inhibition of NOS2 remains withoutconsequences. Alternatively, the differ-
ence between liver and spleenmight result
from a strikingly lower expression of NOS2
in the latter organ.
In the past, counterprotective activities
of NO were largely assigned to the
tissue-damaging and/or immunosup-
pressive effects of high amounts of NO
(Bogdan, 2011). The present study is
interesting with respect to a more direct
impact of NO on pathogen spreading by
attenuating the maturation of secondary
vacuoles. Thus, even 20 years after the
cloning of NOS2, the small inorganic
molecule NO still has to offer surprises.REFERENCES
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The immunologically silent clearance of apoptotic cells is crucial for maintaining self-tolerance. In this issue
of Immunity, Uderhardt et al. (2012) reveal a mechanism by which lipid oxidation by tissue resident macro-
phages could inhibit the engulfment of apoptotic cells by inflammatory monocytes.The death of aged and superfluous cells
and the subsequent engulfment of the
corpses are vital for maintaining tissue
homeostasis and immunological self-
tolerance in multicellular organisms.
Uncleared apoptotic cells can elicit auto-
immunity due to loss of membrane
integrity, resulting in the release of self-
antigens in immunogenic forms. A link
between failed clearance and autoimmu-
nity has been established for diseases
such as systemic lupus erythematosus
(SLE) via studies in human patients and
in mouse models (Mun˜oz et al., 2010;
Nagata et al., 2010).Dying cells are shed or are engulfed
by either neighboring cells or CD11b+
Ly6C resident macrophages (Geiss-
mann et al., 2010; Mosser and Edwards,
2008). Engulfment of uninfected apo-
ptotic cells is usually nonimmunogenic
and does not lead to activation of the
adaptive immune response (Green et al.,
2009). During infection or tissue inflam-
mation, infiltrating CD11b+Ly6C+ inflam-
matory monocytes differentiate into
macrophages and dendritic cells, engulf
extracellular pathogens and/or infected
cells, process foreign-antigen, and have
the potential to drive adaptive antigen-specific T lymphocyte responses (Geiss-
mann et al., 2010). However, engulfment
of apoptotic cells by inflammatory phago-
cytes can also present self-antigen to au-
toreactive T lymphocytes, leading to
a break in self-tolerance (Green et al.,
2009). Our current knowledge of how the
immune system discriminates between
the immunologically silent clearance of
self and the immunogenic clearance of
nonself has primarily focused on the dying
cells and the signals they initiate within the
phagocyte. In this issue of Immunity,
Uderhardt et al. (2012) reveal a potential
mechanism of maintaining self-tolerance36, May 25, 2012 ª2012 Elsevier Inc. 699
